Purple Biotech Ltd Cash Flow-to-Debt Ratio
Purple Biotech Ltd cash flow-to-debt ratio. Purple Biotech Ltd (KTOV) has a Cash Flow-to-Debt Ratio of -0.08x as of June 2020, meaning its operating cash flow of ILA-2.32 Million could theoretically repay 0% of its total liabilities (ILA29.64 Million) in one year. See Purple Biotech Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Purple Biotech Ltd (2013–2019)
Cash flow-to-debt ratio of Purple Biotech Ltd from 2013 to 2019. Historical debt coverage capacity for Purple Biotech Ltd across 7 annual periods. See KTOV net asset quality score to measure how much of total assets are equity-financed.
Purple Biotech Ltd Cash Flow-to-Debt Ratio by Year (2013–2019)
Purple Biotech Ltd cash flow-to-debt ratio by year from 2013 to 2019. Year-by-year debt coverage analysis for Purple Biotech Ltd. For the full cash flow conversion analysis, see cash flow conversion of Purple Biotech Ltd.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2019 | -1.45x | ILA-5.58 Million | ILA3.86 Million | ▲ +36.6% |
| 2018 | -2.28x | ILA-8.48 Million | ILA3.72 Million | ▼ -47.7% |
| 2017 | -1.54x | ILA-8.63 Million | ILA5.59 Million | ▲ +62.3% |
| 2016 | -4.10x | ILA-6.26 Million | ILA1.53 Million | ▼ -71.2% |
| 2015 | -2.39x | ILA-3.31 Million | ILA1.38 Million | ▲ +52.0% |
| 2014 | -4.98x | ILA-4.53 Million | ILA908.00K | ▼ -1123.8% |
| 2013 | -0.41x | ILA-512.00K | ILA1.26 Million | — |